Back
Esquire Financial Holdings, Inc. Vs. Bright Minds Biosciences, Inc. Industry Stock Comparison
Buy
76
ESQ
Esquire Financial Holdings, Inc.
Last Price:
$110.88
Seasonality Move:
-1%
Buy
67
DRUG
Bright Minds Biosciences, Inc.
Last Price:
$90.03
Seasonality Move:
-24.59%
Buy
76
Esquire Financial Holdings, Inc. (ESQ)
is a Buy
Is Esquire Financial Holdings, Inc. a Buy, Sell or Hold?
-
The current Esquire Financial Holdings, Inc. [ESQ] share price is $110.73. The Score for ESQ is 76, which is 52% above its historic median score of 50, and infers lower risk than normal.
-
ESQ is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
67
Bright Minds Biosciences, Inc. (DRUG)
is a Buy
Is Bright Minds Biosciences, Inc. a Buy, Sell or Hold?
-
The current Bright Minds Biosciences, Inc. [DRUG] share price is $90.01. The Score for DRUG is 67, which is 34% above its historic median score of 50, and infers lower risk than normal.
-
DRUG is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
ESQ Stock Price Chart
What is Esquire Financial Holdings, Inc.'s stock price today?
-
The Esquire Financial Holdings, Inc. share price today is $110.73Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and ESQ is experiencing buying pressure, which is a positive indicator for future bullish movement.
DRUG Stock Price Chart
What is Bright Minds Biosciences, Inc.'s stock price today?
-
The Bright Minds Biosciences, Inc. share price today is $90.01Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and DRUG is experiencing slight selling pressure.
ESQ Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 1.25 | Buy |
| Relative Strength Index (14 RSI): | 67.2 | Buy |
| Chaikin Money Flow: | 39286 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (103.47 - 107.65) | Buy |
| Bollinger Bands (100): | (97.11 - 104.89) | Buy |
DRUG Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 4.79 | Buy |
| Relative Strength Index (14 RSI): | 58.71 | Buy |
| Chaikin Money Flow: | -196363 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (75.34 - 89.1) | Buy |
| Bollinger Bands (100): | (46.01 - 75.51) | Buy |
ESQ Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 105.41 | Buy |
| 20-day SMA: | 106.04 | Buy |
| 50-day SMA: | 101.67 | Buy |
| 200-day SMA: | 95.18 | Buy |
| 8-day EMA: | 106.68 | Buy |
| 20-day EMA: | 105.45 | Buy |
| 50-day EMA: | 103.29 | Buy |
| 200-day EMA: | 94.87 | Buy |
DRUG Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 84.17 | Buy |
| 20-day SMA: | 84.39 | Buy |
| 50-day SMA: | 70.26 | Buy |
| 200-day SMA: | 45.73 | Buy |
| 8-day EMA: | 86.85 | Buy |
| 20-day EMA: | 82.54 | Buy |
| 50-day EMA: | 73.48 | Buy |
| 200-day EMA: | 51.43 | Buy |
Esquire Financial Holdings, Inc. Earnings Growth & ESQ Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.12 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.64 per share, and an increase next year of $0.62 per share.
Bright Minds Biosciences, Inc. Earnings Growth & DRUG Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $1.33 per share, a decrease next quarter of $0.00 per share, a decrease this year of $3.03 per share, and a decrease next year of $3.86 per share.
Esquire Financial Holdings, Inc. Technical Analysis
| Dec 23 | Dec 24 | Dec 26 | Dec 29 | Dec 30 | Dec 31 | Jan 5 | Jan 6 | Jan 7 | Jan 8 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | Jan | |||||||||
| 23 | 24 | 26 | 29 | 30 | 31 | 05 | 06 | 07 | 08 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Bright Minds Biosciences, Inc. Technical Analysis
| Dec 22 | Dec 24 | Dec 26 | Dec 29 | Dec 30 | Dec 31 | Jan 5 | Jan 6 | Jan 7 | Jan 8 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | Jan | |||||||||
| 22 | 24 | 26 | 29 | 30 | 31 | 05 | 06 | 07 | 08 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||